Table: Phoenixbio - 9-MTH group results

PhoenixBio

14/02/2025 06:42

Feb 14 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2024        Dec 31, 2023      Mar 31, 2025  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             1.14                1.33              1.52      
                 (-13.9 pct)         (-20.0 pct)       (-11.3 pct)  
  Operating     loss 153 mln           30 mln         loss 253 mln  
                                     (-93.4 pct)                    
  Recurring     loss 146 mln           32 mln         loss 277 mln  
                                     (-92.8 pct)                    
  Net           loss 150 mln           14 mln         loss 281 mln  
                                     (-96.3 pct)                    
  EPS          loss 37.29 yen         3.89 yen       loss 69.54 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T